Most research and biotechnology entities are good at science but need help with their development strategy and the scale up process to treat patients.
We identify promising therapies and bring their development into our POCare Platform to overcome these challenges.
The result: a pipeline of advanced therapies that are expertly and efficiently brought to market for point of care production and use.
Our POCare Platform seeks to accelerate the development of life-changing therapies to potentially reduce costs to the healthcare system.
Partners benefit from Orgenesis’ extensive know-how in CGT process development and validation, and we benefit from long-term economic opportunities through processing licenses and royalties at the POCare Network level.